首頁 > 市場調查報告書 > 製藥

藥物開發

基因毒性檢測市場規模、佔有率和成長分析（按檢測方法、產品、檢測類型、最終用戶和地區分類）—產業預測（2026-2033 年）

市場調查報告書

商品編碼

1902491

基因毒性檢測市場規模、佔有率和成長分析（按檢測方法、產品、檢測類型、最終用戶和地區分類）—產業預測（2026-2033 年）

Genetic Toxicology Testing Market Size, Share, and Growth Analysis, By Testing Methodology (In Vitro Testing, In Vivo Testing), By Product, By Assay Type, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月19日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，基因毒性測試市場規模將達到 16 億美元，到 2025 年將達到 17.2 億美元，到 2033 年將達到 30.2 億美元，在預測期（2026-2033 年）內，複合年成長率為 7.3%。

基因毒性測試在製藥、生物技術和化學工業中發揮著至關重要的作用，用於評估新藥、化學品和消費品的安全性。由於監管審查力度加大、測試技術不斷進步以及公眾健康意識的日益增強，基因毒性測試的重要性與日俱增。研發活動的增加、衛生部門監管的日益嚴格以及人們對長期基因毒性暴露影響的認知不斷提高，使得基因毒性測試市場經歷了顯著成長。雖然傳統的Ames試驗等方法仍然有效，但體外微核試驗和高通量篩檢等新型方法正在提高測試的準確性和效率。此外，採用替代測試方法的趨勢最大限度地減少了動物的使用，並符合倫理標準和監管要求，從而進一步促進了行業內非動物測試模型的應用。

基因毒性檢測市場促進因素

個人和醫療保健專業人員對遺傳健康重要性的認知不斷提高，是推動基因毒性檢測市場發展的關鍵因素。隨著人們意識的增強，越來越多的人開始了解環境暴露（包括化學物質、藥物和污染物）可能帶來的風險。基因毒性檢測在識別這些風險方面發揮關鍵作用，並最終有助於制定個人化的醫療保健解決方案和預防策略。這種認知的加深不僅推動了對檢測患者照護的需求，也促進了基於個人基因譜的主動健康管理。

基因毒性檢測市場限制因素

由於基因資料分析涉及許多倫理問題，基因毒性檢測市場面臨嚴峻的限制。隱私、知情同意以及基因資訊潛在濫用等問題引發了消費者和醫療保健提供者的擔憂。這些因素要求對基因資料進行嚴謹的管理，包括資料的收集、儲存和應用，這就需要嚴格遵守旨在保護個人資訊的法規結構。因此，圍繞這些倫理考量的複雜性可能會阻礙基因毒性檢測的廣泛應用和推廣，最終影響市場成長以及相關人員採用這些先進調查方法的意願。

基因毒性檢測市場趨勢

遺傳毒性檢測市場正迅速採用體外檢測方法，這標誌著傳統動物試驗方法的顯著退化。這項轉變主要得益於以細胞為基礎的檢測方法所具有的諸多優勢，例如最大限度地減少倫理爭議、更快獲得結果、成本效益更高以及與人類生物學的相關性更強。 Ames試驗、微核試驗和彗星試驗等關鍵體外方法因其能夠提供各種物質遺傳毒性和致突變性的準確數據而日益普及。此外，監管機構也鼓勵使用體外技術，進一步加速了其在業界的推廣應用。

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較
主要企業簡介
- 賽默飛世爾科技公司（美國）
- 查爾斯河實驗室國際有限公司（美國）
- 美國實驗室控股公司（美國）
- Eurofins Scientific（德國）
- Jubilant Life Sciences Limited（印度）
- 默克集團（德國）
- Toxikon公司（美國）
- Gentronix有限公司（英國）
- 藥明康德（中國）
- Inotiv公司（美國）
- Creative Bioarray（美國）
- MB 研究實驗室（美國）
- 分子毒理學公司（美國）
- Toxys（荷蘭）
- Syngene International Limited（印度）
- GeneTox Worldwide Inc.（美國）
- Scantox集團（丹麥）
- 科文斯公司（美國）
- BioReliance公司（美國）
- Envigo（美國）

結論與建議

簡介目錄

Product Code: SQMIG35H2189

Genetic Toxicology Testing Market size was valued at USD 1.60 Billion in 2024 and is poised to grow from USD 1.72 Billion in 2025 to USD 3.02 Billion by 2033, growing at a CAGR of 7.3% during the forecast period (2026-2033).

Genetic toxicology testing plays an essential role in the pharmaceutical, biotechnology, and chemical industries by assessing the safety of new drugs, chemicals, and consumer products. Its importance is amplified by increasing regulatory scrutiny, advancements in testing technologies, and a growing focus on public health. The market shows significant expansion driven by rising research and development activities, stringent regulations from health authorities, and increased awareness of long-term genotoxic exposure effects. While traditional methods like the Ames test remain pertinent, newer approaches such as in vitro micronucleus assays and high-throughput screening enhance testing accuracy and efficiency. Additionally, the trend toward alternative testing methods minimizes animal usage, aligning with ethical standards and regulatory requirements, further propelling the adoption of non-animal testing models within the industry.

Top-down and bottom-up approaches were used to estimate and validate the size of the Genetic Toxicology Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Genetic Toxicology Testing Market Segments Analysis

Global Genetic Toxicology Testing Market is segmented by Testing Methodology, Product, Assay Type, End User and region. Based on Testing Methodology, the market is segmented into In Vitro Testing, In Vivo Testing, Computational Toxicology and High-Throughput Screening. Based on Product, the market is segmented into Reagents & Consumables, Assay Kits and Services. Based on Assay Type, the market is segmented into Ames Test, Micronucleus Test, Comet Assay and Chromosomal Aberration Test. Based on End User, the market is segmented into Pharmaceutical Companies, Research Institutions, Contract Research Organizations (CROs) and Government Agencies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Genetic Toxicology Testing Market

The increasing recognition of the significance of genetic health among both individuals and healthcare professionals serves as a critical impetus for the Genetic Toxicology Testing market. As awareness expands, more people seek knowledge about the potential risks linked to environmental exposures, including chemicals, pharmaceuticals, and pollutants. Genetic toxicology testing plays a vital role in this context by facilitating the identification of these risks, ultimately contributing to tailored healthcare solutions and preventative strategies. This growing understanding not only enhances patient care but also fosters a proactive approach to managing health based on individual genetic profiles, bolstering demand for testing services.

Restraints in the Genetic Toxicology Testing Market

The Genetic Toxicology Testing market faces significant restraints stemming from ethical concerns associated with analyzing genetic data. Issues related to privacy, informed consent, and the potential misuse of genetic information create apprehension among consumers and healthcare providers alike. These factors necessitate meticulous management of genetic data, including its collection, storage, and application, which demands strict compliance with regulatory frameworks designed to protect individual information. Consequently, the complexities surrounding these ethical considerations can impede the broader acceptance and implementation of genetic toxicology testing, ultimately affecting market growth and the willingness of stakeholders to adopt these advanced testing methodologies.

Market Trends of the Genetic Toxicology Testing Market

The Genetic Toxicology Testing market is increasingly embracing in vitro testing methods, marking a significant trend away from traditional animal-based approaches. This shift is fueled by the advantages offered by cell-based assays, including minimized ethical concerns, expedited results, cost efficiency, and enhanced relevance to human biology. Prominent in vitro methods like the Ames test, micronucleus assay, and Comet assay are becoming increasingly popular due to their capacity to deliver precise data on the genotoxic and mutagenic potential of various substances. Additionally, regulatory agencies are advocating for the use of in vitro techniques, which further accelerates their adoption within the industry.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies
Regulatory Landscape
Patent Analysis

Global Genetic Toxicology Testing Market Size by Testing Methodology & CAGR (2026-2033)

Market Overview
In Vitro Testing
In Vivo Testing
Computational Toxicology
High-Throughput Screening

Global Genetic Toxicology Testing Market Size by Product & CAGR (2026-2033)

Market Overview
Reagents & Consumables
Assay Kits
Services

Global Genetic Toxicology Testing Market Size by Assay Type & CAGR (2026-2033)

Market Overview
Ames Test
Micronucleus Test
Comet Assay
Chromosomal Aberration Test

Global Genetic Toxicology Testing Market Size by End User & CAGR (2026-2033)

Market Overview
Pharmaceutical Companies
Research Institutions
Contract Research Organizations (CROs)
Government Agencies

Global Genetic Toxicology Testing Market Size & CAGR (2026-2033)

North America (Testing Methodology, Product, Assay Type, End User)
- US
- Canada
Europe (Testing Methodology, Product, Assay Type, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Testing Methodology, Product, Assay Type, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Testing Methodology, Product, Assay Type, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Testing Methodology, Product, Assay Type, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Thermo Fisher Scientific Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Charles River Laboratories International, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Laboratory Corp of America Holdings (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jubilant Life Sciences Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Toxikon Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Gentronix Limited (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
WuXi AppTec (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Inotiv Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Creative Bioarray (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MB Research Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Molecular Toxicology Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Toxys (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Syngene International Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GeneTox Worldwide Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Scantox Group (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Covance Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioReliance Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Envigo (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments